Published in J Clin Oncol on August 01, 1992
The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy. Cancers (Basel) (2016) 0.75
Warfarin and small-cell lung cancer. J Clin Oncol (1993) 0.75
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Dissecting the regulatory circuitry of a eukaryotic genome. Cell (1998) 23.62
Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet (1998) 22.90
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell (1984) 12.30
Pre-mRNA splicing. Annu Rev Genet (1986) 9.86
Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei. Cell (1983) 9.77
Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (1994) 9.37
Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell (1984) 9.13
Transcription activation by the adenovirus E1a protein. Nature (1989) 9.08
Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev (1989) 7.47
Definition of a novel promoter for the major adenovirus-associated virus mRNA. Cell (1980) 7.42
Transcriptional activation of cloned human beta-globin genes by viral immediate-early gene products. Cell (1983) 7.22
Methods to increase response rates to postal questionnaires. Cochrane Database Syst Rev (2007) 7.13
Cloning and domain structure of the mammalian splicing factor U2AF. Nature (1992) 6.55
Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature (1994) 6.55
A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell (1988) 6.16
Mechanism of action of an acidic transcriptional activator in vitro. Cell (1991) 6.04
Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science (1995) 5.97
Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature (1994) 5.95
Senior house officer training: is it getting better? A questionnaire survey. BMJ (1997) 5.61
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
Sequence-specific RNA binding by the HIV-1 Rev protein. Nature (1989) 5.36
Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. Proc Natl Acad Sci U S A (1989) 5.11
A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med (1992) 5.10
Some Atypical Colon-Aerogenes Forms Isolated from Natural Waters. J Bacteriol (1921) 4.91
Binding of general transcription factor TFIIB to an acidic activating region. Nature (1991) 4.71
A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell (1990) 4.67
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med (1990) 4.66
A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature (1990) 4.57
An adenovirus E1a protein region required for transformation and transcriptional repression. Cell (1986) 4.56
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med (2000) 4.54
An ordered pathway of snRNP binding during mammalian pre-mRNA splicing complex assembly. EMBO J (1987) 4.52
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell (1991) 4.43
cis and trans activation of globin gene transcription in transient assays. Proc Natl Acad Sci U S A (1983) 4.41
Transcription factor ATF interacts with the TATA factor to facilitate establishment of a preinitiation complex. Cell (1988) 4.15
An RNA processing activity that debranches RNA lariats. Science (1985) 4.14
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07
The biological concept of race and its application to public health and epidemiology. J Health Polit Policy Law (1986) 4.02
The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature (1993) 3.97
Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst (1996) 3.95
A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Tech (1989) 3.95
A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters. Proc Natl Acad Sci U S A (1987) 3.91
Localization of pre-mRNA splicing in mammalian nuclei. Nature (1995) 3.88
Functional domains of adenovirus type 5 E1a proteins. Cell (1987) 3.79
Functional recognition of the 3' splice site AG by the splicing factor U2AF35. Nature (1999) 3.72
GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell (1988) 3.67
Specific and stable intron-factor interactions are established early during in vitro pre-mRNA splicing. Cell (1985) 3.59
Biochemical characterization of U2 snRNP auxiliary factor: an essential pre-mRNA splicing factor with a novel intranuclear distribution. EMBO J (1991) 3.54
Mammalian nuclei contain foci which are highly enriched in components of the pre-mRNA splicing machinery. EMBO J (1991) 3.49
Interaction of a common cellular transcription factor, ATF, with regulatory elements in both E1a- and cyclic AMP-inducible promoters. Proc Natl Acad Sci U S A (1988) 3.46
Expressing the human genome. Nature (2001) 3.45
A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro. EMBO J (1987) 3.45
Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants. Cell (1985) 3.25
SAGA is an essential in vivo target of the yeast acidic activator Gal4p. Genes Dev (2001) 3.23
Redundant roles for the TFIID and SAGA complexes in global transcription. Nature (2000) 3.21
Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature (1993) 3.16
Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA [corrected]. Science (1996) 3.15
A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev (1988) 3.13
The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev (1991) 3.08
HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science (1993) 3.05
Transcription activation in cells lacking TAFIIS. Nature (1996) 3.04
Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science (1993) 3.03
Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature (1990) 3.03
Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science (2001) 3.03
A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (1995) 2.98
How different eukaryotic transcriptional activators can cooperate promiscuously. Nature (1990) 2.91
Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature (1993) 2.88
The SR protein family: pleiotropic functions in pre-mRNA splicing. Trends Biochem Sci (1996) 2.88
Agmatine: an endogenous clonidine-displacing substance in the brain. Science (1994) 2.83
Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit. Proc Natl Acad Sci U S A (1992) 2.82
Enhancement of TBP binding by activators and general transcription factors. Nature (1999) 2.76
Yeast TAFIIS in a multisubunit complex required for activated transcription. Nature (1994) 2.74
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol (2001) 2.73
Controlling gene expression in living cells through small molecule-RNA interactions. Science (1998) 2.72
U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction. Genes Dev (1997) 2.67
Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc Natl Acad Sci U S A (1991) 2.66
Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern Med (1990) 2.65
Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med (1988) 2.65
Role of the 3' splice site consensus sequence in mammalian pre-mRNA splicing. Nature (1985) 2.63
Splice site selection and ribonucleoprotein complex assembly during in vitro pre-mRNA splicing. Genes Dev (1988) 2.62
Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Am J Epidemiol (1979) 2.56
Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature (1990) 2.47
A note on the biologic concept of race and its application in epidemiologic research. Am Heart J (1984) 2.43
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes Dev (1999) 2.42
Transcripts of the adeno-associated virus genome: mapping of the major RNAs. J Virol (1980) 2.42
Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature (1994) 2.42
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
Distinct classes of yeast promoters revealed by differential TAF recruitment. Science (2000) 2.36
Ribonucleoprotein complex formation during pre-mRNA splicing in vitro. Mol Cell Biol (1986) 2.33
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs (1994) 2.33
Bovine beta-lactoglobulin at 1.8 A resolution--still an enigmatic lipocalin. Structure (1997) 2.23
Coronary arteriography and coronary bypass survey among whites and other racial groups relative to hospital-based incidence rates for coronary artery disease: findings from NHDS. Am J Public Health (1989) 2.21
Targeting of U2AF65 to sites of active splicing in the nucleus. J Cell Biol (1997) 2.21
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest (1998) 2.18
Rising death rates in the Soviet Union: the impact of coronary heart disease. N Engl J Med (1981) 2.17